Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer have?
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer has 718 citations in the OpenAlex counts ScholarIQ stores.
When was Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer published?
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer has 2019 year in the ScholarIQ index.
What is the open-access status of Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer?
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer has green oa status in the ScholarIQ index.
What is the DOI of Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer?
The DOI for Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer is on the source record.
What is the PMID of Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer?
The PMID for Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer is on the source record.
What is the OpenAlex record for Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer?
The OpenAlex for Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer is on the source record.